Neuropeptides
Volume 43, Issue 6 , Pages 507-514 , December 2009

Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress

Received 9 April 2009 ,Accepted 4 August 2009.

References 

  1. Buwalda B, Felszeghy K, Horvath KM, Nyakas C, de Boer SF, Bohus B, et al. Temporal and spatial dynamics of corticosteroid receptor down-regulation in rat brain following social defeat. Physiol. Behav. 2001;72:349–354
  2. Buwalda B, Kole MH, Veenema AH, Huininga M, de Boer SF, Korte SM, et al. Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning. Neurosci. Biobehav. Rev. 2005;29:83–97
  3. Calfa G, Volosin M, Molina VA. Glucocorticoid receptors in lateral septum are involved in the modulation of the emotional sequelae induced by social defeat. Behav. Brain Res. 2006;172:324–332
  4. Chung KK, Martinez M, Herbert J. Central serotonin depletion modulates the behavioural, endocrine and physiological responses to repeated social stress and subsequent c-fos expression in the brains of male rats. Neuroscience. 1999;92:613–625
  5. Covington HE, Miczek KA. Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration “binges”. Psychopharmacol. 2001;158:388–398
  6. Dautzenberg FM, Wichmann J, Higelin J, Py-Lang G, Kratzeisen C, Malherbe P, et al. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64–6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. J. Pharmacol. Exp. Ther. 2001;298:812–819
  7. de Goeij D, Jezova D, Tilders FJ. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res. 1992;577:165–168
  8. Devine DP, Hoversten MT, Ueda Y, Akil H. Nociceptin/orphanin FQ content is decreased in forebrain neurons during acute stress. J. Neuroendocrinol. 2003;15:69–74
  9. Devine DP, Watson SJ, Akil H. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic–hypothalamic–pituitary–adrenal axis. Neuroscience. 2001;102:541–553
  10. Ebner K, Wotjak CT, Landgraf R, Engelmann M. Neuroendocrine and behavioral response to social confrontation: residents versus intruders, active versus passive coping styles. Horm. Behav. 2005;47:14–21
  11. Fernandez F, Misilmeri MA, Felger JC, Devine DP. Nociceptin/orphanin FQ increases anxiety-related behaviour and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology. 2004;29:59–71
  12. Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC, et al. Blockade of nociceptin/orphanin FQ–NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur. J. Neurosci. 2003;17:1987–1990
  13. Gavioli EC, Rae GA, Caló G, Guerrini R, De Lima TC. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Br. J. Pharmacol. 2002;136:764–772
  14. Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, Calo’ G. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides. 2007;28:1229–1239
  15. Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, et al. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch. Pharmacol. 2004;369:547–553
  16. Green MK, Barbieri EV, Brown BD, Chen K-W, Devine DP. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation. Neuropeptides. 2007;41:399–410
  17. Griebel G, Perrault G, Sanger DJ. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res. 1999;836:221–224
  18. Harbuz MS, Lightman SL. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol. 1989;122:705–711
  19. Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 1992;581:190–197
  20. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis. Trends Neurosci. 1997;20:78–84
  21. Jenck F, Moreau J-L, Martin JR, Kilpatrick GJ, Reinscheid RK, Monsma FJ, et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. USA. 1997;94:14854–14858
  22. Jenck F, Wichmann J, Dautzenberg FM, Moreau JL, Ouagazzal AM, Martin JR, et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. USA. 2000;97:4938–4943
  23. Kabbaj M, Devine DP, Savage VR, Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 2000;20:6983–6986
  24. Kamei J, Matsunawa Y, Miyata S, Tanaka S, Saitoh A. Effects of nociceptin on the exploratory behavior of mice in the hole-board test. Eur. J. Pharmacol. 2004;489:77–87
  25. Koolhaas JM, de Boer SF, De Rutter AJ, Meerlo P, Sgoifo A. Social stress in rats and mice. Acta Physiol. Scand. Suppl. 1997;640:69–72
  26. Leggett JD, Harbuz MS, Jessop DS, Fulford AJ. The nociceptin receptor antagonist [Nphe1, Arg14, Lys15]nociceptin/orphanin FQ–NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats. Neuroscience. 2006;141:2051–2057
  27. Martinez M, Phillips PJ, Herbert J. Adaptation in patterns of c-fos expression in the brain associated with exposure to either single or repeated social stress in male rats. Eur. J. Neurosci. 1998;10:20–33
  28. Matsuda S, Peng H, Yoshimura H, Wen TC, Fukuda T, Sakanaka M. Persistent c-fos expression in the brains of mice with chronic social stress. Neurosci. Res. 1996;26:157–170
  29. Miczek KA, Covington HE, Nikulina EM, Hammer RP. Aggression and defeat: persistent effects on cocaine self-administration and gene expression in peptidergic and aminergic mesocorticolimbic circuits. Neurosci. Biobehav. Rev. 2004;27:787–802
  30. Neal CR, Mansour A, Reinscheid RK, Nothacker H-P, Civelli O, Akil H, et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with 125I-[14Tyr]-orphanin FQ binding. J. Comp. Neurol. 1999;412:563–605
  31. Neal CR, Mansour A, Reinscheid RK, Nothacker H-P, Civelli O, Watson SJ. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 1999;406:503–547
  32. Nicholson JR, Akil H, Watson SJ. Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors. Neuroscience. 2002;115:637–643
  33. Nikulina EM, Covington HE, Ganschow L, Hammer RP, Miczek KA. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: fos in the ventral tegmental area and amygdala. Neuroscience. 2004;123:857–865
  34. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press; 1998;
  35. Redrobe JP, Caló G, Regoli D, Quirion R. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn Schmiedebergs Arch. Pharmacol. 2002;365:164–167
  36. Rizzi A, Gavioli EC, Marzola G, Spagnolo B, Zucchini S, Ciccocioppo R, et al. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies. J. Pharmacol. Exp. Ther. 2007;321:968–974
  37. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav. Brain Res. 2005;162:127–134
  38. Tornatzky W, Miczek KA. Long-term impairment of autonomic circadian rhythms after brief intermittent social stress. Physiol. Behav. 1993;53:983–993
  39. Varty GB, Hyde LA, Hodgson RA, Lu SX, McCool MF, Kazdoba TM, et al. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64–6198, in tests of anxiety across multiple species. Psychopharmacology (Berl). 2005;182:132–143
  40. Vitale G, Arletti R, Ruggieri V, Cifani C, Massi M. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides. 2006;27:2193–2200

PII: S0143-4179(09)00084-5

doi: 10.1016/j.npep.2009.08.003

Neuropeptides
Volume 43, Issue 6 , Pages 507-514 , December 2009

Article Tools

* Image Usage & Resolution